Tetra Bio-Pharma Provides Additional Information on CAUMZ Following Type B Meeting with USA FDA

by NASDAQ Market News February 25, 2020

NASDAQ Market News
Click here to email author

Vir Biotechnology and WuXi Biologics Announce Collaboration for Global Development of Antibodies to Treat COVID-19

Aptose to Release Fourth Quarter and Year End December 31, 2019 Financial Results and Hold Conference Call on March 10, 2020

Ads